|
 |
| |
| Licensing & Royalties >> Licensing Opportunities >> Technology Abstracts |
|
| |
Ophthalmology
- Therapeutics:
| Date | Ref. No. | Patent No. | Title | | 5/5/2009 | E-179-2008/0 | | Salcut-NH2: A Novel Target for Development of Anti-Tumorigenic, Anti-Angiogenic Therapeutics and Diagnostics | | 11/1/2008 | E-169-2008/0 | | Methods for Using Interferon Gamma to Absorb Fluid From the Subretinal Space | | 11/1/2008 | E-056-2008/0 | | Treatment and Prevention of Age-Related Macular Degeneration and Other Eye-Related Diseases | | 8/1/2008 | E-140-2008/0 | | Species-Independent A3 Adenosine Receptor Agonists | | 7/1/2008 | E-211-2006/0 | | Therapeutic Application of Fatty Acid Amide Hydrolase Inhibitors | | 2/1/2008 | E-203-2000/0 | 7,144,918 | Biologically Active Macrolides, Compositions and Uses Thereof | | 4/1/2004 | E-008-2004/0 | | Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y | | 7/1/1999 | E-127-1996/0 | 5,998,598 | Immunoadhesins and Methods of Production Thereof | | 5/1/1997 | E-090-1991/0 | 5,328,990
5,656,737 | Macrophage Migration Inhibitory Factor (MIF) | | 7/1/1996 | E-185-1992/1
E-185-1992/4 | 5,840,686 | Pigment Epithelium Derived Factor: Characterization of Its Novel Biological Activity and Sequences Encoding and Expressing the Protein | | 7/1/1996 | E-185-1992/3
E-185-1992/4 | 6,319,687
7,179,621 | Pigment Epithelium Derived Factor: Characterization, Genomic Organization and Sequence of PEDF Gene |
|
| Back |
|
|
|
|
|
|